Two PHS Agencies, FDA and IHS, use program funds instead of the 1
percent set-aside to conduct their evaluations. FDA programs are principally
authorized by legislation other than the PHS Act, specifically the authority of
the Federal Food, Drug, and Cosmetic Act, and funds are appropriated under the
Agriculture, Rural Development, Food and Drug Administration and Related
Agencies Appropriations Act. IHS programs are authorized under the Indian
Health Care Improvement Act and the Indian Self-Determination Act, and funds
are appropriated under the Department of the Interior and Related Agencies
Appropriations Act.
In addition to using the set-aside authority for the PHS Agencies and
OASH, Congress has used it over the past decade to support special program
activities of the National Center for Health Statistics and the Agency for
Health Care Policy and Research. Furthermore, the Office of the Secretary has
used the authority to support public health-related surveys and high-priority
evaluation activities.
The National Institute of Allergy and Infectious Diseases (NIAID),
the National Heart, Lung, and Blood Institute (NHLBI), and the National
Institute of Environmental Health Sciences (NIEHS).
Oral poliovirus vaccine; hepatitis B vaccine; and measles, mumps, and
rubella.
Diphtheria, tetanus, pertussis vaccine.
ATSDR, an agency of the Public Health Service, is closely aligned
with but not part of CDC. For the purposes of this study, ATSDR was defined as
a CDC activity.
